Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
RF Quote, Financials, Valuation and Earnings
Last price:
$24.56
Seasonality move
:
2.16%
Day range:
$23.96 - $24.61
52-week range:
$17.74 - $27.96
Dividend yield:
4.08%
P/E ratio:
11.78x
P/S ratio:
3.15x
P/B ratio:
1.31x
Volume:
10.2M
Avg. volume:
9.8M
1-year change:
10.85%
Market cap:
$22B
Revenue:
$7.1B
EPS (TTM):
$2.08
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.4B | $7.2B | $7.6B | $7.1B | |
| Revenue Growth (YoY) | 7.36% | 2.57% | 11.33% | 5.74% | -6.51% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.2B | $2.4B | $2.4B | $2.5B | $2.6B | |
| Other Inc / (Exp) | $54M | $6M | -$1M | -$5M | -$208M | |
| Operating Expenses | $2.1B | $2.3B | $2.4B | $2.3B | $2.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | $3.2B | $2.9B | $2.6B | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $220M | $694M | $631M | $533M | $461M | |
| Net Income to Company | $1.1B | $2.5B | $2.2B | $2.1B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $2.5B | $2.2B | $2.1B | $1.9B | |
| Basic EPS (Cont. Ops) | $1.03 | $2.51 | $2.29 | $2.11 | $1.94 | |
| Diluted EPS (Cont. Ops) | $1.03 | $2.49 | $2.28 | $2.11 | $1.93 | |
| Weighted Average Basic Share | $959M | $956M | $935M | $936M | $916M | |
| Weighted Average Diluted Share | $962M | $963M | $942M | $938M | $918M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.7B | $3.4B | $3.2B | $4.2B | $4.6B | |
| Revenue (Reported) | $6.3B | $6.4B | $7.2B | $7.6B | $7.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.7B | $3.4B | $3.2B | $4.2B | $4.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $2B | $1.7B | $1.8B | |
| Revenue Growth (YoY) | 11.89% | -0.62% | 22.01% | -10.46% | 2.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $578M | $584M | $668M | $728M | $675M | |
| Other Inc / (Exp) | $5M | -- | -$2M | -$50M | -$25M | |
| Operating Expenses | $570M | $583M | $666M | $727M | $675M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $822M | $702M | $789M | $464M | $621M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $180M | $154M | $177M | $96M | $131M | |
| Net Income to Company | $642M | $548M | $612M | $368M | $490M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $642M | $548M | $612M | $368M | $490M | |
| Basic EPS (Cont. Ops) | $0.64 | $0.56 | $0.63 | $0.37 | $0.51 | |
| Diluted EPS (Cont. Ops) | $0.63 | $0.55 | $0.62 | $0.37 | $0.51 | |
| Weighted Average Basic Share | $961M | $938M | $935M | $921M | $906M | |
| Weighted Average Diluted Share | $968M | $947M | $942M | $923M | $910M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $868M | $739M | $1B | $1B | $1.2B | |
| Revenue (Reported) | $1.6B | $1.6B | $2B | $1.7B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $868M | $739M | $1B | $1B | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.4B | $6.4B | $7.5B | $7.4B | $7.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.3B | $2.3B | $2.5B | $2.6B | $2.6B | |
| Other Inc / (Exp) | $59M | -- | -$3M | -$53M | -$183M | |
| Operating Expenses | $2.2B | $2.3B | $2.4B | $2.4B | $2.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.9B | $3.1B | $3B | $2.3B | $2.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $358M | $668M | $654M | $452M | $496M | |
| Net Income to Company | $1.6B | $2.4B | $2.3B | $1.8B | $2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $2.4B | $2.3B | $1.8B | $2B | |
| Basic EPS (Cont. Ops) | $1.52 | $2.43 | $2.37 | $1.84 | $2.08 | |
| Diluted EPS (Cont. Ops) | $1.51 | $2.40 | $2.34 | $1.84 | $2.08 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.2B | $3.3B | $3.5B | $4.2B | $4.8B | |
| Revenue (Reported) | $6.4B | $6.4B | $7.5B | $7.4B | $7.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.2B | $3.3B | $3.5B | $4.2B | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $2B | $1.7B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $578M | $584M | $668M | $728M | $675M | |
| Other Inc / (Exp) | $5M | -- | -$2M | -$50M | -$25M | |
| Operating Expenses | $570M | $583M | $666M | $727M | $675M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $822M | $702M | $789M | $464M | $621M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $180M | $154M | $177M | $96M | $131M | |
| Net Income to Company | $642M | $548M | $612M | $368M | $490M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $642M | $548M | $612M | $368M | $490M | |
| Basic EPS (Cont. Ops) | $0.64 | $0.56 | $0.63 | $0.37 | $0.51 | |
| Diluted EPS (Cont. Ops) | $0.63 | $0.55 | $0.62 | $0.37 | $0.51 | |
| Weighted Average Basic Share | $961M | $938M | $935M | $921M | $906M | |
| Weighted Average Diluted Share | $968M | $947M | $942M | $923M | $910M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $868M | $739M | $1B | $1B | $1.2B | |
| Revenue (Reported) | $1.6B | $1.6B | $2B | $1.7B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $868M | $739M | $1B | $1B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18B | $29.4B | $11.2B | $6.8B | $10.7B | |
| Short Term Investments | $27.2B | $28.5B | $27.9B | $28.1B | $23.4B | |
| Accounts Receivable, Net | $346M | $319M | $511M | $614M | $572M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $45.5B | $58.2B | $39.7B | $35.5B | $34.7B | |
| Property Plant And Equipment | $1.9B | $1.8B | $1.7B | $1.6B | $1.7B | |
| Long-Term Investments | $29.5B | $30.6B | $30B | $30.3B | $32.3B | |
| Goodwill | $5.2B | $5.7B | $5.7B | $5.7B | $5.7B | |
| Other Intangibles | $418M | $723M | $1.1B | $1.1B | $1.2B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $147.4B | $162.9B | $155.2B | $152.2B | $157.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $500M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $500M | |
| Long-Term Debt | $3.6B | $2.4B | $2.3B | $2.3B | $6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $129.3B | $144.6B | $139.3B | $134.7B | $139.4B | |
| Common Stock | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | |
| Other Common Equity Adj | $1.3B | $289M | -$3.3B | -$2.8B | -$2.9B | |
| Common Equity | $16.5B | $16.7B | $14.3B | $15.8B | $16.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $4M | $64M | $31M | |
| Total Equity | $18.1B | $18.3B | $16B | $17.5B | $17.9B | |
| Total Liabilities and Equity | $147.4B | $162.9B | $155.2B | $152.2B | $157.3B | |
| Cash and Short Terms | $45.1B | $57.9B | $39.2B | $34.9B | $34.2B | |
| Total Debt | $3.6B | $2.4B | $2.3B | $2.3B | $6.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $24.9B | $27.9B | $8.8B | $11.3B | $14.3B | |
| Short Term Investments | $25.9B | $26.6B | $25.1B | $25.6B | $23.1B | |
| Accounts Receivable, Net | $336M | $329M | $538M | $588M | $583M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $51.1B | $54.9B | $34.5B | $37.4B | $38B | |
| Property Plant And Equipment | $1.9B | $1.8B | $1.7B | $1.6B | $1.7B | |
| Long-Term Investments | $29.4B | $31.8B | $30.4B | $30.1B | $32.5B | |
| Goodwill | $5.2B | $5.7B | $5.7B | $5.7B | $5.7B | |
| Other Intangibles | $515M | $834M | $1B | $1.2B | $1.1B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $153.3B | $164.1B | $154.1B | $154.9B | $159.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $2B | $1B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $2B | $1B | -- | |
| Long-Term Debt | $2.9B | $2.3B | $2.3B | $3.3B | $6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $135.5B | $147.1B | $137.2B | $137.8B | $141.3B | |
| Common Stock | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | |
| Other Common Equity Adj | $592M | -$1.2B | -$2.8B | -$3.2B | -$2.3B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $19M | $34M | $37M | |
| Total Equity | $17.9B | $17B | $16.9B | $17.1B | $18.6B | |
| Total Liabilities and Equity | $153.3B | $164.1B | $154.1B | $154.9B | $159.8B | |
| Cash and Short Terms | $50.8B | $54.6B | $34B | $36.8B | $37.4B | |
| Total Debt | $2.9B | $2.3B | $4.3B | $4.3B | $6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $2.5B | $2.2B | $2.1B | $1.9B | |
| Depreciation & Amoritzation | $421M | $371M | $353M | $236M | $144M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$246M | -$231M | -$2.2B | $194M | -$831M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $3B | $3.1B | $2.3B | $1.6B | |
| Capital Expenditures | $59M | $72M | $288M | $157M | $146M | |
| Cash Acquisitions | -$381M | -$1.2B | -- | -- | -- | |
| Cash From Investing | -$4.9B | -$2.9B | -$12.9B | -$1.6B | -$262M | |
| Dividends Paid (Ex Special Dividend) | -$698M | -$716M | -$762M | -$885M | -$994M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $4.7B | $647M | -- | $2B | $3.7B | |
| Long-Term Debt Repaid | -$10.9B | -$1.8B | -- | -$2B | -$100M | |
| Repurchase of Common Stock | -- | -$967M | -$230M | -$252M | -$848M | |
| Other Financing Activities | -$11M | -$19M | -$24M | -$35M | -$27M | |
| Cash From Financing | $16.4B | $11.3B | -$8.3B | -$5.1B | $2.6B | |
| Beginning Cash (CF) | $4.1B | $18B | $29.4B | $11.2B | $6.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.8B | $11.5B | -$18.2B | -$4.4B | $3.9B | |
| Ending Cash (CF) | $18B | $29.4B | $11.2B | $6.8B | $10.7B | |
| Levered Free Cash Flow | $2.3B | $3B | $2.8B | $2.2B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $642M | $548M | $612M | $368M | $490M | |
| Depreciation & Amoritzation | $101M | $105M | $63M | $48M | $22M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$96M | -$163M | $297M | -$130M | $300M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $719M | $584M | $196M | $396M | $1.1B | |
| Capital Expenditures | $11M | $69M | $18M | $119M | $5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$67M | -$3.6B | -$1.1B | $1.2B | $166M | |
| Dividends Paid (Ex Special Dividend) | -$177M | -$185M | -$211M | -$247M | -$252M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1B | -- | |
| Long-Term Debt Repaid | -$632M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$215M | -- | -$102M | -$242M | |
| Other Financing Activities | -$2M | -$1M | -- | -$1M | -$2M | |
| Cash From Financing | $6.3B | $1.5B | -$1.5B | $2.8B | $2.4B | |
| Beginning Cash (CF) | $18B | $29.4B | $11.2B | $6.8B | $10.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7B | -$1.5B | -$2.4B | $4.4B | $3.6B | |
| Ending Cash (CF) | $24.9B | $27.9B | $8.8B | $11.3B | $14.3B | |
| Levered Free Cash Flow | $708M | $515M | $178M | $277M | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $2.4B | $2.3B | $1.8B | $2B | |
| Depreciation & Amoritzation | $422M | $375M | $311M | $221M | $118M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$383M | -$298M | -$1.8B | -$233M | -$401M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $2.9B | $2.7B | $2.5B | $2.3B | |
| Capital Expenditures | $66M | $130M | $237M | $258M | $32M | |
| Cash Acquisitions | -$381M | -- | -- | -- | -- | |
| Cash From Investing | $360M | -$6.4B | -$10.4B | $698M | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -$703M | -$724M | -$788M | -$921M | -$999M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $3B | $2.7B | |
| Long-Term Debt Repaid | -$9.8B | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$1.2B | -$15M | -$354M | -$988M | |
| Other Financing Activities | -$13M | -$18M | -- | -$36M | -$28M | |
| Cash From Financing | $17B | $6.5B | -$11.4B | -$789M | $2.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.7B | $3B | -$19.1B | $2.4B | $3.1B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.2B | $2.8B | $2.5B | $2.3B | $2.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $642M | $548M | $612M | $368M | $490M | |
| Depreciation & Amoritzation | $101M | $105M | $63M | $48M | $22M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$96M | -$163M | $297M | -$130M | $300M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $719M | $584M | $196M | $396M | $1.1B | |
| Capital Expenditures | $11M | $69M | $18M | $119M | $5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$67M | -$3.6B | -$1.1B | $1.2B | $166M | |
| Dividends Paid (Ex Special Dividend) | -$177M | -$185M | -$211M | -$247M | -$252M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1B | -- | |
| Long-Term Debt Repaid | -$632M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$215M | -- | -$102M | -$242M | |
| Other Financing Activities | -$2M | -$1M | -- | -$1M | -$2M | |
| Cash From Financing | $6.3B | $1.5B | -$1.5B | $2.8B | $2.4B | |
| Beginning Cash (CF) | $18B | $29.4B | $11.2B | $6.8B | $10.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7B | -$1.5B | -$2.4B | $4.4B | $3.6B | |
| Ending Cash (CF) | $24.9B | $27.9B | $8.8B | $11.3B | $14.3B | |
| Levered Free Cash Flow | $708M | $515M | $178M | $277M | $1.1B | |
Get RF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RF
Sector
P/E ratio
11.78x
12.21x
PEG ratio
0.90x
0.40x
P/B ratio
1.31x
1.11x
Price / LTM sales
3.15x
2.66x
Growth Metrics
RF
Sector
Revenue growth
2.12%
5.12%
Earnings growth
37.84%
2.63%
Revenue (5-year growth)
3.92%
5.17%
Earnings forecast
$0.56
$0.61
Profitability
RF
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
8.44%
5.21%
Return on assets
1.29%
0.97%
Return on equity
11.26%
9.24%
Earnings Date
Last Earnings Date
Apr
17
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Jul
17
Balance Sheet
RF
Sector
Total cash
$37.4B
$451.2M
Short term investments
$23.4B
$220.9M
Total assets
$157.3B
$3.8B
Long term debt
$6B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
